Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patients F. Kanefendt, A. Lindauer, M. Kinzig, D. Strumberg, M.E. Scheulen, K. Mross, R. Fischer, B. Moritz, F. Sörgel, U. Jaehde
F. Kanefendt, A. Lindauer, M. Kinzig, D. Strumberg, M.E. Scheulen, K. Mross, R. Fischer, B. Moritz, F. Sörgel and U. Jaehde.Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patients.2011; 49: 88-90. doi: .
during a check of our data we have observed, that we don't have your current E-Mail address on file. We would like to ask you to send it to us, in case we need to contact you. You can send us an E-Mail to [email protected] or call us under +49-89-613861-0.
